Patents by Inventor Johnatan Bacon

Johnatan Bacon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CRUSH-RESISTANT TABLETS INTENDED TO PREVENT ACCIDENTAL MISUSE AND UNLAWFUL DIVERSION
    Publication number: 20150246035
    Abstract: Water-insoluble matrix tablets which are capable of prolonged release of active principles liable to be diverted for drug addiction purposes, the said active principles being dispersed within a tabletting matrix composed of at least one excipient selected from the group consisting of pH-independent, water-insoluble delay polymers, inorganic excipients and mixtures thereof, and exhibiting a crush resistance of at least 4 MPa.
    Type: Application
    Filed: April 29, 2015
    Publication date: September 3, 2015
    Applicant: ETHYPHARM SA
    Inventors: Vincent CAILLY-DUFESTEL, Catherine HERRY, Johnatan BACON, Pascal OURY
  • Crush-resistant oxycodone tablets intended for preventing accidental misuse and unlawful diversion
    Patent number: 8501160
    Abstract: Water-insoluble matrix tablets based on oxycodone or one of its pharmaceutically acceptable salts and capable of prolonged release of oxycodone to the body, exhibiting a crush resistance of at least 4 MPa.
    Type: Grant
    Filed: March 1, 2007
    Date of Patent: August 6, 2013
    Assignee: Ethypharm SA
    Inventors: Vincent Cailly-Dufestel, Catherine Herry, Johnatan Bacon, Pascal Oury
  • Controlled-release compositions
    Patent number: 8487002
    Abstract: A solid dosage formulation having a core with a pharmacological agent dispersed in a first controlled-release matrix from which release of the agent is relatively slow; and a coat formed over the core and having the agent dispersed in a second controlled-release matrix from which release of the agent is relatively fast. The first matrix can be a cross-linked high amylose starch and the second matrix can be a mixture of polyvinyl acetate and polyvinylpyrrolidone.
    Type: Grant
    Filed: April 22, 2005
    Date of Patent: July 16, 2013
    Assignees: Paladin Labs Inc., Paladin Labs (Barbados) Inc., Paladin Labs Europe Limited
    Inventors: Vincent Lenaerts, Patricia Laure Ouadji-Njiki, Johnatan Bacon, Rachid Ouzerourou, Sonia Gervais, Miloud Rahmouni, Damon Smith
  • Controlled-release compositions
    Publication number: 20100151022
    Abstract: A solid dosage formulation having a core with a pharmacological agent dispersed in a first controlled-release matrix from which release of the agent is relatively slow; and a coat formed over the core and having the agent dispersed in a second controlled-release matrix from which release of the agent is relatively fast. The first matrix can be a cross-linked high amylose starch and the second matrix can be a mixture of polyvinyl acetate and polyvinylpyrrolidone.
    Type: Application
    Filed: April 22, 2005
    Publication date: June 17, 2010
    Inventors: Vincent Lenaerts, Laure Ouadji-Njiki, Johnatan Bacon, Rachid Ouzerourou, Sonia Gervais, Miloud Rahmouni, Damon Smith
  • Crush-Resistant Tablets Intended to Prevent Accidental Misuse and Unlawful Diversion
    Publication number: 20100015223
    Abstract: Water-insoluble matrix tablets which are capable of prolonged release of active principles liable to be diverted for drug addiction purposes, the said active principles being dispersed within a tabletting matrix composed of at least one excipient selected from the group consisting of pH-independent, water-insoluble delay polymers, inorganic excipients and mixtures thereof, and exhibiting a crush resistance of at least 4 MPa.
    Type: Application
    Filed: March 1, 2007
    Publication date: January 21, 2010
    Inventors: Vincent Cailly-Dufestel, Catherine Herry, Johnatan Bacon, Pascal Oury
  • Sustained-release tramadol formulations with 24-hour efficacy
    Publication number: 20090047345
    Abstract: A sustained-release tramadol formulation oral administration is provided which, upon initial administration of one dose, provides an analgesic effect within 2 hours, which analgesic effect continues for at least 24 hours after administration
    Type: Application
    Filed: April 22, 2005
    Publication date: February 19, 2009
    Inventors: Vincent Lenaerts, Laure Ouadji-Njiki, Johnatan Bacon, Rachid Ouzerourou, Sonia Gervais, Miloud Rahmouni, Damon Smith
  • Crush-Resistant Oxycodone Tablets Intended For Preventing Accidental Misuse And Unlawful Diversion
    Publication number: 20090011016
    Abstract: Water-insoluble matrix tablets based on oxycodone or one of its pharmaceutically acceptable salts and capable of prolonged release of oxycodone to the body, exhibiting a crush resistance of at least 4 MPa.
    Type: Application
    Filed: March 1, 2007
    Publication date: January 8, 2009
    Inventors: Vincent Cailly-Dufestel, Catherine Herry, Johnatan Bacon, Pascal Oury
  • Sustained-release tramadol formulations with 24-hour efficacy
    Publication number: 20070003618
    Abstract: A sustained-release tramadol formulation oral administration is provided which, upon initial administration of one dose, provides an analgesic effect within 2 hours, which analgesic effect continues for at least 24 hours after administration
    Type: Application
    Filed: April 22, 2005
    Publication date: January 4, 2007
    Inventors: Vincent Lenaerts, Laure Patricia Ouadji-Njiki, Johnatan Bacon, Rachid Ouzerourou, Sonia Gervais, Miloud Rahmouni, Damon Smith
  • Controlled-release compositions
    Publication number: 20060240107
    Abstract: A solid dosage formulation having a core with a pharmacological agent dispersed in a first controlled-release matrix from which release of the agent is relatively slow; and a coat formed over the core and having the agent dispersed in a second controlled-release matrix from which release of the agent is relatively fast. The first matrix can be a cross-linked high amylose starch and the second matrix can be a mixture of polyvinyl acetate and polyvinylpyrrolidone.
    Type: Application
    Filed: April 22, 2005
    Publication date: October 26, 2006
    Inventors: Vincent Lenaerts, Laure Ouadji-Njiki, Johnatan Bacon, Rachid Ouzerourou, Sonia Gervais, Miloud Rahmouni, Damon Smith
  • Prolamin-based sustained-release compositions and delayed-onset compositions
    Publication number: 20020106408
    Abstract: In one embodiment, the invention relates to sustained-release compositions comprising one or more prolamins, one or more gelling agents, and one or more active agents. Such compositions are particularly useful for controlled delivery of high solubility and/or high dosage active agents. In another embodiment, the present invention relates to delayed-onset compositions comprising a dry coating comprising one or more prolamins and one or more gelling agents.
    Type: Application
    Filed: December 1, 2000
    Publication date: August 8, 2002
    Inventors: Johnatan Bacon, Alain Desjardins